CagriSema is a fixed-dose combination obesity medication made by Novo Nordisk, the same Danish company that makes Wegovy and Ozempic
For severe cases, the first dose is usually 1,000 mcg given intramuscularly every day or every other day for a week or two
Cell Metab (2018) 28(4):55772.e6
For lasting or permanent tans, fading will accelerate with professional methods such as laser or chemical peels
Estrogen has been shown to impact collagen synthesis and wound healing, suggesting that hormonal regulation may play a role in the rehabilitation of ACL injuries
GLP-1 receptor agonists Including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are peptide-based drugs that have completed full FDA review and carry approved indications for type 2 diabetes and obesity